BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹273 Cr | ₹308 Cr | ₹279 Cr | ₹257 Cr | ₹226 Cr |
What is the latest Total Expenditure of BAL PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹257 Cr |
| Mar2021 | ₹226 Cr |
How is Total Expenditure of BAL PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | -11.34 | |
| Mar2024 | ₹308 Cr | 10.51 | |
| Mar2023 | ₹279 Cr | 8.45 | |
| Mar2022 | ₹257 Cr | 13.88 | |
| Mar2021 | ₹226 Cr | - | |
Compare Total Expenditure of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹125.5 Cr | -8.7% | 3.7% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -8.7% |
3.7% |
-18.8% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses